Analytic for Hemodynamic Instability (AHI) vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Analytic for Hemodynamic Instability (AHI)

by Fifth Eye Inc.

Tempus ECG-Low EF

by Tempus

AI Verdict

Tool A is designed for continuous, real-time monitoring of adult in-hospital patients to predict acute hemodynamic instability hours in advance. Tool B analyzes single 12-lead ECGs to detect signs associated with chronic low left ventricular ejection fraction in patients at risk of heart failure. Therefore, Tool A is suited for proactive critical care management, while Tool B serves as a diagnostic aid for heart failure risk assessment.

Choose Analytic for Hemodynamic Instability (AHI) if…

Choose Analytic for Hemodynamic Instability (AHI) if you require continuous, real-time monitoring of adult in-hospital patients to proactively detect early signs of hemodynamic instability. This tool is ideal for critical care settings where early warnings, hours ahead of traditional vital signs, can enable timely interventions and reduce nurse surveillance burden.

View Analytic for Hemodynamic Instability (AHI) →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if you need to screen patients aged 40 or older for signs associated with low left ventricular ejection fraction using a standard 12-lead ECG. This software is best suited for identifying patients at risk of heart failure in clinical diagnostic settings, aiding clinicians in determining the need for further evaluation.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Analytic for Hemodynamic Instability (AHI)	Tempus ECG-Low EF
Deployment	Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution.	Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Analytic for Hemodynamic Instability (AHI)	Tempus ECG-Low EF
Company	Fifth Eye	Tempus AI
Product Name	Analytic for Hemodynamic Instability (AHI)	Tempus ECG-Low EF
Primary Function	Continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs.	Analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure.
Data Input	Continuous ECG lead II data	Resting, non-ambulatory 12-lead ECG recordings
Output	Easy-to-interpret visual indicators (red, yellow, green)	Binary output (Low LVEF Detected / Not Detected)
Target Patient Population	Adult in-hospital patients receiving continuous physiological monitoring with ECG.	Patients 40 years of age or older at risk of heart failure.
Lead Time/Prediction Window	Up to 26 hours for AHI-PI (predicts hemodynamic instability earlier than vital signs).	Not specified

Videos

Demos, reviews, and walkthroughs featuring Analytic for Hemodynamic Instability (AHI) and Tempus ECG-Low EF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in the clinical problem each tool addresses?

AHI focuses on predicting acute hemodynamic instability in adult in-hospital patients hours before traditional vital signs, providing early warnings for proactive care. Tempus ECG-Low EF, conversely, analyzes 12-lead ECGs to detect signs associated with chronic low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure, aiding in further evaluation.

What specific patient data does each tool require for its analysis?

AHI continuously uses ECG lead II data from adult in-hospital patients for real-time analytics. Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings from patients 40 years or older.

How do the outputs of AHI and Tempus ECG-Low EF differ, and what action does each suggest?

AHI provides continuous, easy-to-interpret visual indicators (red, yellow, green) for early warnings of hemodynamic instability, prompting increased clinical vigilance and proactive intervention. Tempus ECG-Low EF provides a binary output ('Low LVEF Detected / Not Detected') to aid clinicians in further evaluation for heart failure risk, and is not intended as a standalone diagnostic tool.

How do these tools integrate into existing hospital or clinic workflows?

AHI is a Software as a Medical Device (SaMD) integrated into in-hospital monitoring platforms and accessible via any browser-enabled device. Tempus ECG-Low EF is software integrated into healthcare facility workflows, intended for use in clinical diagnostic settings.

What are the primary benefits each tool offers to healthcare professionals?

AHI aims to reduce nurse surveillance burden, streamline workflow, and enable proactive patient care by predicting instability earlier than vital signs. Tempus ECG-Low EF aids in identifying patients 40+ years at risk of heart failure, supporting clinicians in further evaluation and earlier detection of serious cardiovascular conditions.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Analytic for Hemodynamic Instability (AHI) or Tempus ECG-Low EF

Backers

Who funded each tool's parent company.